A detailed history of Quadrant Capital Group LLC transactions in Accolade, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 45 shares of ACCD stock, worth $158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Previous 45 -0.0%
Holding current value
$158
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$10.45 - $15.02 $2,194 - $3,154
-210 Reduced 82.35%
45 $0
Q1 2023

May 11, 2023

BUY
$7.32 - $14.38 $1,515 - $2,976
207 Added 431.25%
255 $3,000
Q4 2022

Feb 10, 2023

SELL
$7.19 - $13.16 $905 - $1,658
-126 Reduced 72.41%
48 $0
Q3 2022

Nov 10, 2022

BUY
$0.0 - $12.8 $0 - $550
43 Added 32.82%
174 $2,000
Q2 2022

Aug 09, 2022

SELL
$5.28 - $18.9 $269 - $963
-51 Reduced 28.02%
131 $1,000
Q1 2022

May 06, 2022

BUY
$12.92 - $27.18 $1,925 - $4,049
149 Added 451.52%
182 $3,000
Q4 2021

Feb 01, 2022

BUY
$21.96 - $42.69 $724 - $1,408
33 New
33 $1,000

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $254M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.